Clinical management and treatment of hypertension, its pathophysiology and the clinical use of antihypertensive drugs

被引：0
作者：
Lip, Gregory Y. H. [1 ]
机构：
[1] Univ Birmingham Hosp, Dept Med, Birmingham B18 7QH, W Midlands, England
来源：
CURRENT PHARMACEUTICAL DESIGN | 2006年 / 12卷 / 13期
关键词：
D O I：
10.2174/138161206776843359
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1555 / 1555
页数：1
相关论文
共 6 条
  • [1] Is hypertension an inflammatory process?
    Boos, Christopher J.
    Lip, Gregory Y. H.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (13) : 1623 - 1635
  • [2] Perception of symptoms in hypertensive patients and the relevance to the application of anti-hypertensive drug therapy
    Goyal, Efeepak
    MacFadyen, Robert J.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (13) : 1557 - 1565
  • [3] Traditional risk factors for coronary atherosclerosis in Indo Asians: The need for a reappraisal
    Jaumdally, J. Rumi
    Lip, Gregory Y. H.
    Varma, Chetan
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (13) : 1611 - 1621
  • [4] The role of hyperglycaemia and the hypercoagulable state in the pathogenesis of cardiovascular events in diabetes mellitus: Implications for hypertension management
    Lim, Hoong Sern
    MacFadyen, Robert J.
    Bakris, George
    Lip, Gregory Y. H.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (13) : 1567 - 1579
  • [5] Target organ damage in hypertension: Pathophysiology and implications for drug therapy
    Nadar, Sunil K.
    Tayebjee, Muzahir H.
    Messerli, Franz
    Lip, Gregory Y. H.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (13) : 1581 - 1592
  • [6] Novel concepts of statin therapy for cardiovascular risk reduction in hypertension
    Varughese, George I.
    Patel, Jeetesh V.
    Lip, Gregory Y. H.
    Varma, Chetan
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (13) : 1593 - 1609
1